We have located links that may give you full text access.
Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study.
Cancer Epidemiology, Biomarkers & Prevention 2018 October 18
BACKGROUND: Adiposity has been linked to both risk and prognosis of colorectal cancer; however, the impact of different fat areas [visceral (VFA) vs. subcutaneous fat area (SFA)] is unclear. We investigated associations between adiposity and biomarkers of inflammation and angiogenesis among patients with colorectal cancer.
METHODS: Preoperative serum samples and computed tomography scans were obtained from 188 patients diagnosed with primary invasive stage I-IV colorectal cancer enrolled in the ColoCare Study. Adiposity was assessed by area-based quantification of VFA, SFA, and VFA:SFA ratio on spinal levels L3/L4 and L4/L5. Circulating levels of inflammation (CRP, SAA, sICAM-1, sVCAM-1) and angiogenesis (VEGF-A, VEGF-D) were assessed from patient sera on the Meso-Scale-Discoveries platform. Partial correlations and regression analyses, adjusted for age, sex, and tumor stage, were performed.
RESULTS: VFA was moderately correlated with CRP and SAA (CRP: L3/L4 and L4/L5:r=0.21, p=0.01; SAA: L3/L4:r=0.17, p=0.04). The correlation between SFA and the measured biomarkers were weak (r≤0.13, not significant). The ratio of VFA:SFA at L3/L4 was moderately correlated with VEGF-A (r=0.28, p=0.0008), and SAA (r=0.24, p=0.006), and less so with CRP (r=0.18, p=0.04) and sICAM-1 (r=0.18, p=0.04). Similar correlations were found for VFA:SFA ratio at L4/L5.
CONCLUSIONS: We observed an association between visceral adiposity and biomarkers of inflammation and angiogenesis in colorectal cancer patients. In particular, the VFA:SFA ratio was correlated with circulating levels of pro-angiogenic biomarker VEGF-A.
IMPACT: Our findings support a direct association of visceral adipose tissue with inflammatory and angiogenic processes, which play fundamental roles in the development and progression of colorectal cancer.
METHODS: Preoperative serum samples and computed tomography scans were obtained from 188 patients diagnosed with primary invasive stage I-IV colorectal cancer enrolled in the ColoCare Study. Adiposity was assessed by area-based quantification of VFA, SFA, and VFA:SFA ratio on spinal levels L3/L4 and L4/L5. Circulating levels of inflammation (CRP, SAA, sICAM-1, sVCAM-1) and angiogenesis (VEGF-A, VEGF-D) were assessed from patient sera on the Meso-Scale-Discoveries platform. Partial correlations and regression analyses, adjusted for age, sex, and tumor stage, were performed.
RESULTS: VFA was moderately correlated with CRP and SAA (CRP: L3/L4 and L4/L5:r=0.21, p=0.01; SAA: L3/L4:r=0.17, p=0.04). The correlation between SFA and the measured biomarkers were weak (r≤0.13, not significant). The ratio of VFA:SFA at L3/L4 was moderately correlated with VEGF-A (r=0.28, p=0.0008), and SAA (r=0.24, p=0.006), and less so with CRP (r=0.18, p=0.04) and sICAM-1 (r=0.18, p=0.04). Similar correlations were found for VFA:SFA ratio at L4/L5.
CONCLUSIONS: We observed an association between visceral adiposity and biomarkers of inflammation and angiogenesis in colorectal cancer patients. In particular, the VFA:SFA ratio was correlated with circulating levels of pro-angiogenic biomarker VEGF-A.
IMPACT: Our findings support a direct association of visceral adipose tissue with inflammatory and angiogenic processes, which play fundamental roles in the development and progression of colorectal cancer.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app